DG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0) (BioCAD00000021105)

blood feces all tissues

Metabolite Card

Formula: C41H68O5 (640.5066)
SMILES: [H][C@](CO)(COC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC

Synonyms [en]

1-Oleoyl-2-eicosapentaenoyl-sn-glycerol; 1-(9Z-Octadecenoyl)-2-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-sn-glycerol; DG(38:6); DG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0); DAG(18:1/20:5); DG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)[iso2]

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

DG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0). 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000021105). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

DG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of eicosapentaenoic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the eicosapentaenoic acid moiety is derived from fish oils, liver and kidney. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

Entity Information

DBLinks

Other DBLinks
  • PubChem: 9543797
  • ChEBI: ChEBI:89218
  • HMDB: HMDB0007230
  • LipidMaps: LMGL02010132
  • Metlin: METLIN_4441
  • Coconut NaturalProduct: CNP0084464.1

Class / Ontology

Metabolic Network
ID EC Number Name
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
PathBank:SMP0066572 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:0)
PathBank:SMP0066576 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PathBank:SMP0066580 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
PathBank:SMP0033202 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:2(11Z,14Z))
PathBank:SMP0070176 Phosphatidylcholine Biosynthesis PC(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0075328 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
PathBank:SMP0075332 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0082428 Phosphatidylethanolamine Biosynthesis PE(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0086937 Phosphatidylcholine Biosynthesis PC(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0087674 Phosphatidylethanolamine Biosynthesis PE(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0090597 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:0)
PathBank:SMP0090601 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PathBank:SMP0090605 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
PathBank:SMP0022515 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z))
PathBank:SMP0022519 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
PathBank:SMP0022523 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
PathBank:SMP0022527 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
PathBank:SMP0022531 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0066571 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0066575 De Novo Triacylglycerol Biosynthesis TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
View All Pathways